Roche boosts its antibody arsenal with a $489M buyout

Damian Garde

is betting big on antibodies that can attack two targets at once, signing on to buy Austria's Dutalys for as much as $ 488.8 million and get its hands on some proprietary technology.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS